Tag: basis

- BEACON2 is a landmark European multi-arm, multi-stage Phase 1/2 platform trial conducted and sponsored by the Cancer Research UK Clinical Trials Unit (CRCTU), University of Birmingham 

- Elraglusib will be assessed in combination with dinutuximab beta plus chemotherapy in patients with relapsed and refractory neuroblastoma

- Complete response in neuroblastoma patient achieved in Phase 1 study of elraglusib in refractory pediatric cancers

GUANGZHOU, China, June 09, 2026 (GLOBE NEWSWIRE) -- EHang Holdings Limited (Nasdaq: EH) (“EHang” or the “Company”), the world’s leading advanced air mobility (“AAM”) technology platform company, today announced its unaudited financial results for the first quarter ended March 31, 2026.

Progress on share buyback programme

HOUSTON, June 09, 2026 (GLOBE NEWSWIRE) -- VAALCO Energy, Inc. (NYSE: EGY, LSE: EGY) (“Vaalco” or the “Company”) announced that the Baobab field on CI-40 block, offshore Côte d’Ivoire is back online following the successful Baobab Ivoirien Floating Production Storage and Offloading vessel (“FPSO”) refurbishment.

Das Unternehmen stellt unter den Marken TCL SunPower und TCL / TCL Solar zahlreiche neue Produkte vor und treibt damit seine Vision eines integrierten Energie-Ökosystems für Privathaushalte sowie den Gewerbe- und Industriesektor voran.

NEW YORK, June 08, 2026 (GLOBE NEWSWIRE) -- GraniteShares has announced it will execute forward shares split for the several funds (the “Funds”). The total market value of the shares outstanding will not be affected as a result of these splits.

Acquisition of Calavo Growers completed May 28, 2026